Platelet-activating-factor-mediated pathogenesis in Lyme disease

Infection and Immunity

Volumn 64, Issue 3, 1996, Pages 1026-1029

  Isogai, Emiko ^a   Kimura, Koichi ^b   Fujii, Nobuhiro ^b   Nishikawa, Takeshi ^b   Ishii, Norihisa ^c   Postic, Daniele ^d   Baranton, Guy ^d   Isogai, Hiroshi ^b  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; [2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL SKIN DISEASE; BORRELIA BURGDORFERI; BORRELIA INFECTION; CONTROLLED STUDY; INFLAMMATION; LYME DISEASE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 0030043396     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.3.1026-1029.1996     Document Type: Article

References (34)

1. Ambrosio, G., A. Oriente, C. Napoli, G. Palumbo, P. Chiariello, G. Marone, M. Condorelli, M. Chiariello, and M. Triggiani. 1994. Oxygen radicals inhibit human plasma acethylhydrase, the enzyme that catabolizes platelet-activating factor. J. Clin Invest 93:2408-2416.
2. Baranton, G., D. Postic, I. Saint Girons, P. Boerlin, J. C. Piffaretti, M. Assous, and P. A. Grimont. 1992 Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J. Syst. Bacteriol. 42:378-383.
3. Barbour, A. G. 1984. Isolation and cultivation of Lyme disease spirochetes Yale J. Biol. Med. 57:521-525.
4. Barett, M. L., G. P. Lewis, S. Ward, and J. Westwich. 1987. Platelet activating factor induces interleukin-1 production from human adherent macrophages Br J Pharmacol. 90:113P. (Abstract.)
5. Beck, G. L., J. Benach, and G. S. Habicht. 1989 Isolation of interleukin 1 from joint fluids of patients with Lyme disease. J. Rheumatol 16:800-806.
6. Benach, J. L., H. B. Fleit, G. S. Habicht, J. L. Coleman, E. M. Bosler, and B. P. Lane. 1984. Interactions of phagocytes with the Lyme disease spirochete role of the Fc receptor. J. Infect. Dis. 150:497-507.
7. Berger, B. W., O. J. Clemmensen, and A. B. Ackerman. 1983. Lyme disease is a spirochetosis. a review of the disease and evidence of its cause. Am J Dermatopathol. 5:111-124.
8. Braquet, P., L. Touqui, T. Y. Shen, and B. B. Vargaftig. 1987. Perspectives in platelet-activating factor research Pharmacol. Rev. 39:97-145.
9. Burgdorfer, W. 1984. The New Zealand white rabbit, an experimental host for infecting ticks with Lyme disease spirochetes. Yale J. Biol. Med. 57:609-612.
10. Burgdorfer, W., A. G. Barbour, S. F. Hayes, J. L. Benach, E. Grunwalt, and J. P. Davis. 1982. Lyme disease - a tick-borne spirochetosis. Science 216:1317-1319.
11. Coburn, J., S. W. Barthold, and J. M. Leong. 1994. Diverse Lyme disease spirochetes bind integrin αIIbβ3 on human platelets. Infect. Immun. 62:5559-5567.
12. Coburn, J., J. M. Leong, and J. K. Erban. 1993. Integrin aIIbB3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets Proc Soc. Acad. Sci. USA 90:7059-7063.
13. Comstock, L. E., and D. D. Thomas. 1989. Penetration of endothelial cell monolayers by Borrelia burgdorfert. Infect. Immun 57:1626-1628.
14. Defosse, D. L., and R. C. Johnson. 1992. In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect. Immun. 60:1109-1113.
15. Galbe, J. L., E. Guy, J. M. Zapatero, E. I. Peerschke, and J. L. Benach. 1993. Vascular clearance of Borrelia burgdorferi in rats. Microb. Pathogen. 14:187-201.
16. Georgilis, K., A. C. Steere, and M. S. Klempner. 1991. Infectivity of Borrelia burgdorferi correlates with resistance to elimination by phagocytic cells. J. Infect. Dis. 163:150-155.
17. Hanahan, D. J. 1986. Platelet activating factor: a biologically active phosphoglyceride. Annu. Rev. Biochem 55:483-509.
18. Isogai, E., S. Tanaka, I. S. Braga III, C. Itakura, H. Isogai, K. Kimura, and N. Fujii. 1994 Experimental Borrelia garinii infection of Japanese quail. Infect. Immun. 62:3580-3582.
19. Kornblatt, A. N., A. C. Steere, and D. G. Brownstein. 1984. Infection of rabbits with the Lyme disease spirochete. Yale J. Biol. Med. 57:613-614.
20. Lynch, J. M., and P. M. Henson. 1986. The intracellular retension of newly synthesized platelet-activating factor. J. Immunol. 137:2653-2661.
21. Ma, Y., and J. J. Weis. 1993. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell-mitogenic and cytokine-stimulatory properties. Infect Immun. 61:3843-3853.
22. Oda, M., K. Satouchi, K. Yasunaga, and K. Saito. 1986. Polymorphonuclear leukocyte-platelet interactions: acetylglyceryl ether phosphocholine-induced platelet activation under stimulation with chemotactic peptide. J. Biochem. 100:1117-1123.
23. Peterson, P. K., C. C. Clawson, D. A. Lee, D. J. Garlich, P. G. Quie, and R. C. Johnson. 1984. Human phagocyte interactions with the Lyme disease spirochete. Infect Immun 46:608-611.
24. Pleszczynski, M. R. 1990. Priming of human monocytes with PAF augments their production of tumor necrosis factor. J Lipid Med. 2:S77-S82.
25. Prescott, S. M., G. A. Zimmerman, and T. M. McIntyre. 1984. Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc. Natl Acad. Sci USA 81:3534-3538.
26. Schmidli, J., T. Hunziker, P. Moesli, and U. B. Schaad. 1988. Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis. J. Infect. Dis. 158:905-906.
27. Shoberg, R. J., and D. D. Thomas. 1993. Specific adherence of Borrelia burgdorferi extracellular vesicles to human endothelial cells in culture. Infect. Immun. 61:3892-3900.
28. Snydman, D. R., D. P. Schenkein, V. P. Berardi, C. C. Lastavica, and K. M. Pariser. 1986. Borrelia burgdorferi in joint fluids in chronic Lyme arthritis. Ann. Inern Med 194:798-800.
29. Stafforini, D. M., S. M. Prescott, and T. M. McIntyre. 1987. Human plasma platelet-activating factor acethylanhydrase: purification and properties. J. Biol. Chem. 262:4215-4222
30. Szczepanski, A., and H. B. Fleit. 1988. Interaction between Borrelia burgdorferi and polymorphonuclear leukocytes: phagocytosis and the induction of the respiratory burst. Ann. N Y. Acad Sci. 539:425-428.
31. Tanaka, M. 1989. Induction of tissue factor-like activity of human monoblastic leukemia cell line by tumor necrosis factor-alpha. Thromb. Res 56:201-211.
32. Terashita, Z., S. Tsushima, Y. Yoshida, H. Nomura, Y. Inada, and K. Nishikawa. 1983. CV-3988, a specific antagonist of platelet activating factor (PAF). Life Sci. 32:1975-1982.
33. Wallace, J. L., and B. J. R. Whittle. 1986. Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. Prostaglandins 31:989-998.
34. Wardlow, M. L., C. P. Cox, K. E. Meng, D. E. Green, and R. S. Farr. 1986. Substrate specificity and partial characterization of the PAF-acethylhydrase in human serum that rapidly inactivates platelet-activating factor J. Immunol. 136:3441-3446.